Building a better drug | Spectrum | Autism Research News
Iama Therapeutics is hoping a new class of molecule will prove successful against an old target in autism.
Stanford University United States Eteläuomen Läi Noord Holland Yehezkel Ben Jeremy Veenstra Vanderweele
Source: spectrumnews.org